SAM 2025

Back

27 - 29 March 2025 Bilbao, Spain

ISS1 - Transforming Healthcare: The Introduction of the First Omalizumab Biosimilar

Friday 28 Mar, 12:00 PM - 13:00 PM Bilbao, Spain

Room 0C Industry Sponsored Session

12:00

Demystifying biosimilars: Foundations and Future

12:30

Taking a closer look to the first EMA-approved omalizumab biosimilar in Chronic Spontaneous Urticaria